Skip to content

Clinical trials

Phase 2 Uterine Cervical Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 2 Country / region: United States Clear all

163 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20026
20034
20048
20057
200611
20076
20085
20097
20101
20115
20125
20131
20154
20162
20178
201810
20193
20207
20214
20226
20236
20247
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Terminated31
Recruiting23
Active, not recruiting10
Unknown status7
Withdrawn5
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
Gynecologic Oncology Group21
M.D. Anderson Cancer Center7
Dana-Farber Cancer Institute4
Washington University School of Medicine4
Masonic Cancer Center, University of Minnesota3
Memorial Sloan Kettering Cancer Center3
University of California, San Diego3
University of Oklahoma3
Daiichi Sankyo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms163
Endometrial Neoplasms29
Ovarian Neoplasms27
Vaginal Neoplasms18
Vulvar Neoplasms17
Esophageal Neoplasms16
Breast Neoplasms15
Carcinoma, Non-Small-Cell Lung13
Stomach Neoplasms12
Urinary Bladder Neoplasms12

Trials

Showing 1 to 25 of 163. Each trial links to its page on Pharma Observatory.

63 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.